SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1990Dr. Una Ryan Departs AVANT Immunotherapeutics Wednesday May 14, 8:00 am ET NEEDIcebrg-5/15/2008
1989J&J exec says psoriasis drug could dominate field Wed May 14, 2008 11:02pm BIcebrg-5/15/2008
1988DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEE DATE AND TIME: June 17-18,Icebrg-5/14/2008
1987The share is on somewhat of a run this morning. I first believed that someone haIcebrg-5/13/2008
1986Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of UlcIcebrg-5/12/2008
1985Dynamic Programmed Death 1 Expression by Virus-Specific CD8 T Cells Correlates WIcebrg-5/6/2008
1984A Phase 1 Open-Label, Single-Dose, Dose-Escalation Study of Mdx-1100, a High-AffIcebrg-5/4/2008
1983J&J merges Ortho Biotech, Centocor sales, slashes 400 jobs Ben Comer May 01,Icebrg-5/2/2008
1982Medarex has consistently claimed that FDA's decision will be based on the &qIcebrg-4/26/2008
1981Erik, I see your point about good news disguised as bad, but isn't dacarbaziA.J. Mullen-4/25/2008
1980Medarex (MEDX, Trade ) shares slid 12% to $7.04. Shortly before the end of the rLJM-4/25/2008
1979I suppose this is sort of good news disguised as bad news. I.e. FDA appears willIcebrg-4/25/2008
1978Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of IpilimuA.J. Mullen-4/25/2008
1977Not bad considering what they once paid for the drug: <i>Located in BloomIcebrg-4/16/2008
1976Pfizer and AVANT Enter into Licensing and Development Agreement for Novel TherapLJM-4/16/2008
1975Significant Tumor-Specific Immune Response Observed in AVANT's Phase 2 TrialIcebrg-4/16/2008
1974Efficacy and safety of a human anti-CD70 antibody-MGBA conjugate Abstract NumbeIcebrg-4/15/2008
1973Preclinical development of anti B7-H4 therapeutic antibodies Presentation Start/Icebrg-4/15/2008
1972CTLA-4 blockade for hormone refractory prostate cancer: Dose-dependent inductionIcebrg-4/15/2008
1971New insights into targeting T cell negative pathway in tumor immunity Abstract Icebrg-4/15/2008
1970Induction of powerful secondary immune response by blocking T cell negative pathIcebrg-4/15/2008
1969Dendritic and T cell functions in patients with metastatic hormone-refractory prIcebrg-4/15/2008
1968Increased doses of an anti-CD30 antibody, MDX-060, results in prolonged progressIcebrg-4/14/2008
1967Combination of dendritic cell (DC) vaccination with CTLA4 blockade in patients (Icebrg-4/14/2008
1966Novartis: ACZ885 Has Potential In Autoinflammatory Diseases4-8-08 5:12 AM EDT | Icebrg-4/14/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News